Allogene Therapeutics Inc (ALLO)
3.37
-0.03
(-0.88%)
USD |
NASDAQ |
Apr 23, 16:00
3.37
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Total Assets (Quarterly): 642.84M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 642.84M |
| September 30, 2023 | 712.33M |
| June 30, 2023 | 770.97M |
| March 31, 2023 | 746.87M |
| December 31, 2022 | 821.58M |
| September 30, 2022 | 887.57M |
| June 30, 2022 | 947.64M |
| March 31, 2022 | 964.63M |
| December 31, 2021 | 1.051B |
| September 30, 2021 | 1.079B |
| June 30, 2021 | 1.127B |
| March 31, 2021 | 1.179B |
| Date | Value |
|---|---|
| December 31, 2020 | 1.228B |
| September 30, 2020 | 1.222B |
| June 30, 2020 | 1.259B |
| March 31, 2020 | 688.52M |
| December 31, 2019 | 717.80M |
| September 30, 2019 | 695.54M |
| June 30, 2019 | 734.00M |
| March 31, 2019 | 749.37M |
| December 31, 2018 | 773.86M |
| September 30, 2018 | 435.24M |
| June 30, 2018 | 298.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
642.84M
Minimum
Dec 2023
1.259B
Maximum
Jun 2020
919.74M
Average
887.57M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Agenus Inc | 313.91M |
| ANI Pharmaceuticals Inc | 904.42M |
| Vaxart Inc | 91.83M |
| aTyr Pharma Inc | 120.65M |
| PAVmed Inc | 33.12M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 130.60M |
| Shareholders Equity (Quarterly) | 512.23M |
| Current Ratio | 12.38 |